Qingjun Li
Zhengzhou University
2 Papers
Qingjun Li is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Cancer & Apoptosis. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
RASSF7 promotes cell proliferation through activating MEK1/2-ERK1/2 signaling pathway in hepatocellular carcinoma.
Min Zhang,Qiong Li,Lu Zhang,Yunjian Wang,Linxia Wang,Qingjun Li,Tao He,Baishun Wan,Xiaoqian Wang +8 more
TL;DR: A novel evidence for clinical significance of RASSF7 as a potential biomarker is provided, and it is demonstrated that RassF7- MEK1/2-ERK 1/2 signaling pathway might be a novel pathway involved in HCC progression.
Anti-silencing function 1B promotes the progression of pancreatic cancer by activating c-Myc
Min Zhang,Luyang Zhang,Minghe Zhou,En-ye Wang,Bo Meng,Qingjun Li,Xiaoqian Wang,Yunjian Wang,Qing Li +8 more
TL;DR: The present study aimed to explore the role of histone chaperone anti-silencing function 1B (ASF1B) in pancreatic cancer and the underlying mechanism and promoted pancreatic cancers progression by activating c-Myc via CBP-mediated H3K56ac.